Literature DB >> 26124228

Tamper-resistant drugs cannot solve the opioid crisis.

Pamela Leece1, Aaron M Orkin2, Meldon Kahan2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26124228      PMCID： PMC4500686          DOI： 10.1503/cmaj.150329

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Drug-poisoning deaths involving heroin: United States, 2000-2013.

Authors:  Holly Hedegaard; Li-Hui Chen; Margaret Warner
Journal:  NCHS Data Brief       Date:  2015-03

2.  Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse.

Authors:  Theodore J Cicero; Michael Lynskey; Alexandre Todorov; James A Inciardi; Hilary L Surratt
Journal:  Pain       Date:  2008-05-01       Impact factor: 6.961

3.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

Review 4.  Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions.

Authors:  Nathaniel Katz; Richard C Dart; Elise Bailey; Jeremiah Trudeau; Eric Osgood; Florence Paillard
Journal:  Am J Drug Alcohol Abuse       Date:  2011-04-26       Impact factor: 3.829

Review 5.  The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Authors:  Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander
Journal:  Annu Rev Public Health       Date:  2015-01-12       Impact factor: 21.981

6.  Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border.

Authors:  Tara Gomes; J Michael Paterson; Mariam Mukati; David Henry
Journal:  CMAJ Open       Date:  2015-04-02

7.  Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

8.  Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada.

Authors:  Parvaz Madadi; Doris Hildebrandt; Albert E Lauwers; Gideon Koren
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation.

Authors:  Nelson E Sessler; Jerod M Downing; Hrishikesh Kale; Howard D Chilcoat; Todd F Baumgartner; Paul M Coplan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-11       Impact factor: 2.890
  9 in total
  10 in total

1.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

Review 2.  Current State of Opioid Therapy and Abuse.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

3.  Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.

Authors:  Andrea L Schaffer; Nicholas A Buckley; Louisa Degenhardt; Briony Larance; Rose Cairns; Timothy A Dobbins; Sallie-Anne Pearson
Journal:  CMAJ       Date:  2018-03-26       Impact factor: 8.262

Review 4.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

5.  The opioid crisis: past, present and future policy climate in Ontario, Canada.

Authors:  Kristen A Morin; Joseph K Eibl; Alexandra M Franklyn; David C Marsh
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-11-02

6.  How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.

Authors:  Andreas Kimergård; Paolo Deluca; Peter Hindersson; Torben Breindahl
Journal:  Pain Ther       Date:  2016-06-13

7.  Identification of factors influencing tampering of codeine-containing medicines in England: a qualitative study.

Authors:  Andreas Kimergård; Stephen Parkin; Stacey Jennings; Eileen Brobbin; Paolo Deluca
Journal:  Harm Reduct J       Date:  2020-09-11

8.  The opioid crisis: a contextual, social-ecological framework.

Authors:  Mohammad S Jalali; Michael Botticelli; Rachael C Hwang; Howard K Koh; R Kathryn McHugh
Journal:  Health Res Policy Syst       Date:  2020-08-06

9.  Review of Coroner Inquest Recommendations into Opioid Prescribing Practices in Ontario: Ongoing Health Policy Gaps.

Authors:  Nicholas Papadomanolakis-Pakis; Kieran Moore; Julia Lew; Maximilien Boulet
Journal:  Healthc Policy       Date:  2019-08

10.  A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.

Authors:  Kristen A Morin; Chad R Prevost; Joseph K Eibl; Michael T Franklyn; Alexander R Moise; David C Marsh
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.